title: Pharmacokinetics of the inodilator XB513 in mice, rats, guinea pigs, rabbits, dogs, and monkeys.
authors.affiliation: DuPont Merck Pharmaceutical Company, Drug Metabolism and Pharmacokinetics Section, Stine-Haskell Research Center, Newark, DE 19714.
authors.forename: H F
authors.initials: HF
authors.lastname: Stampfli
authors.forename: C R
authors.initials: CR
authors.lastname: Person
authors.forename: S M
authors.initials: SM
authors.lastname: Huang
authors.forename: C Y
authors.initials: CY
authors.lastname: Quon
mesh_terms: D000818:Animals; D001682:Biological Availability; D002120:Calcium Channel Agonists / Q000493:pharmacokinetics*; D002851:Chromatography, High Pressure Liquid; D004095:Dihydropyridines / Q000493:pharmacokinetics*; D004285:Dogs; D005260:Female; D006168:Guinea Pigs; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010879:Piperazines / Q000493:pharmacokinetics*; D011817:Rabbits; D051381:Rats; D013045:Species Specificity
chemical_list: D002120:Calcium Channel Agonists; D004095:Dihydropyridines; D010879:Piperazines; C081663:XB 513